FIREBRICK PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.05 AUD | 0.00% |
|
-1.96% | 0.00% |
| Jun. 13 | Firebrick Pharma Launches Nasodine Nasal Spray in Singapore | MT |
| May. 23 | Firebrick Pharma Obtains Nasodine Composition Patent in South Africa | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 6.56M | - | - | - | - | - | |
| 848B | ||||||
| 627B | ||||||
| 363B | ||||||
| 318B | ||||||
| 299B |
